Asset
PRALICIGUAT
Cyclerion Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02906579 | phase2 | completed | 2016-09-01 | 2017-03-17 | Cyclerion Therapeutics | A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension |
| NCT03499106 | phase1 | completed | 2018-04-12 | 2018-07-06 | Cyclerion Therapeutics | A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers |
| NCT02616861 | phase1 | completed | 2015-11-01 | 2016-05-01 | Cyclerion Therapeutics | Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers |
| NCT03091920 | phase2 | completed | 2017-02-28 | 2017-08-03 | Cyclerion Therapeutics | Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension |
FDA applications (0)
This company has no applications containing this asset.